A direct adverse effect of smoking

by Christos Kyriakopoulos, Athena Gogali, Christos Chronis, Konstantinos Kostikas
Published 2021-01-01

Identification and treatment of T2-low asthma in the era of biologics

by Chris Kyriakopoulos, Athena Gogali, Konstantinos Bartziokas, Konstantinos Kostikas
Published 2021-06-01

Hypercoagulable State in COPD-A Comprehensive Literature Review

by Christos Kyriakopoulos, Athena Gogali, Konstantinos Kostikas, Athanasios Konstantinidis
Published 2021-08-01

Primary care and COVID-19: cutting the Gordian knot – the Greek experience and algorithm

by Ioannis Tomos, Konstantinos Kostikas, Georgios Hillas, Petros Bakakos, Stelios Loukides
Published 2020-08-01

Prevalence and determinants of current cigarette smoking and secondhand smoking among Greek adolescents: the Global Youth Tobacco Survey (GYTS) 2013 study

by Anastasia Barbouni, Konstantinos Kostikas, Athanasios Basagiannis, Varvara Mouchtouri, Kyriakoula Merakou, Jenny Kremastinou
Published 2020-02-01

A 68-year-old man with haemoptysis and extensive ipsilateral lung infiltrates

by Chris Kyriakopoulos, Athena Gogali, Konstantinos Tatsis, Nektarios Anagnostopoulos, Grigoris Stratakos, Konstantinos Kostikas
Published 2021-03-01

Validation of the portable Bluetooth® Air Next spirometer in patients with different respiratory diseases

by Konstantinos P. Exarchos, Athena Gogali, Agni Sioutkou, Christos Chronis, Sofia Peristeri, Konstantinos Kostikas
Published 2020-04-01

Control of asthma in real life: still a valuable goal?

by Andriana I. Papaioannou, Konstantinos Kostikas, Eleftherios Zervas, Lykourgos Kolilekas, Spiridon Papiris, Mina Gaga
Published 2015-06-01

Outpatient Management of COVID-19 Disease: A Holistic Patient-Centered Proposal Based on the Greek Experience

by Adamantia Liapikou, Eleni Tzortzaki, Georgios Hillas, Miltiadis Markatos, Ilias C. Papanikolaou, Konstantinos Kostikas
Published 2021-07-01

Association of TLR4-T399I Polymorphism with Chronic Obstructive Pulmonary Disease in Smokers

by Matthaios Speletas, Vassiliki Merentiti, Konstantinos Kostikas, Kyriaki Liadaki, Markos Minas, Konstantinos Gourgoulianis, Anastasios E. Germenis
Published 2009-01-01

Efficacy of indacaterol/glycopyrronium versus salmeterol/fluticasone in current and ex-smokers: a pooled analysis of IGNITE trials

by David M.G. Halpin, Claus F. Vogelmeier, Karen Mezzi, Pritam Gupta, Konstantinos Kostikas, Jadwiga A. Wedzicha
Published 2021-02-01

The Epidemiology of Pulmonary Nontuberculous Mycobacteria: Data from a General Hospital in Athens, Greece, 2007–2013

by Marios Panagiotou, Andriana I. Papaioannou, Konstantinos Kostikas, Maria Paraskeua, Ekaterini Velentza, Maria Kanellopoulou, Vasiliki Filaditaki, Napoleon Karagiannidis
Published 2014-01-01

Bronchoscopic diagnosis and treatment of endobronchial carcinoid: case report and review of the literature

by Anastasia Papaporfyriou, Julian Domayer, Michael Meilinger, Irene Firlinger, Georg-Christian Funk, Ulrike Setinek, Konstantinos Kostikas, Arschang Valipour
Published 2021-01-01

Body composition in severe refractory asthma: comparison with COPD patients and healthy smokers.

by Markos Minas, Andriana I Papaioannou, Agori Tsaroucha, Zoe Daniil, Chrissi Hatzoglou, Markos Sgantzos, Konstantinos I Gourgoulianis, Konstantinos Kostikas
Published 2010-01-01

Evaluation of exacerbations and blood eosinophils in UK and US COPD populations

by Claus F. Vogelmeier, Konstantinos Kostikas, Juanzhi Fang, Hengfeng Tian, Bethan Jones, Christopher Ll Morgan, Robert Fogel, Florian S. Gutzwiller, Hui Cao
Published 2019-08-01

Patients' perspectives on COPD: findings from a social media listening study

by Nigel S. Cook, Konstantinos Kostikas, Jean-Bernard Gruenberger, Bhavik Shah, Purnima Pathak, Vinay Preet Kaur, Alaknanda Mudumby, Rajat Sharma, Florian S. Gutzwiller
Published 2019-02-01

Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study

by Antonio R. Anzueto, Konstantinos Kostikas, Karen Mezzi, Steven Shen, Michael Larbig, Francesco Patalano, Robert Fogel, Donald Banerji, Jadwiga A. Wedzicha
Published 2018-06-01

Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME study

by Jadwiga A. Wedzicha, Dave Singh, Ioanna Tsiligianni, Christine Jenkins, Sebastian Fucile, Robert Fogel, Steven Shen, Pankaj Goyal, Karen Mezzi, Konstantinos Kostikas
Published 2019-01-01

Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study

by Alexander J. Mackay, Konstantinos Kostikas, Nicolas Roche, Stefan-Marian Frent, Petter Olsson, Pascal Pfister, Pritam Gupta, Francesco Patalano, Donald Banerji, Jadwiga A. Wedzicha
Published 2020-04-01

Treatment response in COPD: does FEV1 say it all? A post hoc analysis of the CRYSTAL study

by Konstantinos Kostikas, Timm Greulich, Alexander J. Mackay, Nadine S. Lossi, Maryam Aalamian-Mattheis, Xavier Nunez, Veronica A. Pagano, Francesco Patalano, Andreas Clemens, Claus F. Vogelmeier
Published 2019-02-01